1722 The unique contribution of ion channels to platelet and megakaryocyte function 1733 Activated protein C reasons to believe 1736 Activated protein C modulates cardiac metabolism and augments …
1979. Phase III studies on novel oral anticoagulant for stroke prevention in atrial fibrillation a look beyond the excellent results 1988. Contemporary managementof primary immune thrombocytopenia…
2215 Regulators of G protein signaling role in hematopoiesis megakaryopoises and platelet function 2223 The evolution and value of bleeding assesment tools 2230 Anticoagulants in cancer 2242 Reg…
2418 The future of glycoprotein VI as an antiihrombotic target 2428 Von willebrand factor the old the new and the unknown 2438 Air pollution, vascular disease and thrombosis linking clinical data…
2 Platelet based coagulation different populations different functions 17 Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome 26 Plasminogen receptors and their role…
223. Coagulation and cancer biological and clinical 234.New developments in the area of factor XIII 245. Laboratory assesment of the anticoagulant effects of the next generation of oral anticoagu…
576. Which test to use to measure the anticoagulant effect of rivaroxaban the prothrombin 579. Which test to use measure the anticoagulant effect of rivaroxaban 581. Weibel palade bodies a window…
327 Response variability to clopidogrel is tailored treatment based on laboratory testing the right solution 337 Exogenous activated protein C inhibits the progression of diabetic nephropathy 34…
985 safety of catheter delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion 992 Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal …
1207. The impact of blood coagulabillity on atherosclerosis and cardiovascular disease 1217. Aspirin twice a day keeps new COX-1 at bay 1220. The recovery of platelet cyclooxygenase activity expl…